Your browser doesn't support javascript.
loading
Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway.
Adesso, L; Calabretta, S; Barbagallo, F; Capurso, G; Pilozzi, E; Geremia, R; Delle Fave, G; Sette, C.
Affiliation
  • Adesso L; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Oncogene ; 32(23): 2848-57, 2013 Jun 06.
Article in En | MEDLINE | ID: mdl-22797067

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Protein Serine-Threonine Kinases / Carcinoma, Pancreatic Ductal / Eukaryotic Initiation Factor-4E / Deoxycytidine / Intracellular Signaling Peptides and Proteins / Antimetabolites, Antineoplastic Type of study: Prognostic_studies Limits: Aged80 Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2013 Document type: Article Affiliation country: Italy Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Protein Serine-Threonine Kinases / Carcinoma, Pancreatic Ductal / Eukaryotic Initiation Factor-4E / Deoxycytidine / Intracellular Signaling Peptides and Proteins / Antimetabolites, Antineoplastic Type of study: Prognostic_studies Limits: Aged80 Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2013 Document type: Article Affiliation country: Italy Country of publication: United kingdom